Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Is Chemours Co (NYSE:CC) a Good Stock To Buy?

Most investors tend to think that hedge funds and other asset managers are worthless, as they cannot beat even simple index fund portfolios. In fact, most people expect hedge funds to compete with and outperform the bull market that we have witnessed over the past few years. However, hedge funds are generally partially hedged and aim at delivering attractive risk-adjusted returns rather than following the ups and downs of equity markets hoping that they will outperform the broader market. Our research shows that hedge funds do have great stock picking skills, so let’s take a glance at the smart money sentiment towards Chemours Co (NYSE:CC).

Chemours Co (NYSE:CC) was in 24 hedge funds’ portfolios at the end of September. CC investors should pay attention to an increase in enthusiasm from smart money in recent months. There were 10 hedge funds in our database with CC positions at the end of the previous quarter. At the end of this article we will also compare CC to other stocks including Granite Construction Inc. (NYSE:GVA), Potlatch Corporation (NASDAQ:PCH), and Hyster-Yale Materials Handling Inc (NYSE:HY) to get a better sense of its popularity.

Follow Chemours Co (NYSE:CC)
Trade (NYSE:CC) Now!

Now, let’s review the recent action encompassing CC.

Hedge fund activity in Chemours Co (NYSE:CC)

Heading into Q4, a total of 24 of the hedge funds tracked by Insider Monkey held long positions in this stock, a change of 140% from one quarter earlier. With the smart money’s sentiment swirling, there exists an “upper tier” of noteworthy hedge fund managers who were upping their holdings significantly (or already accumulated large positions).

According to publicly available hedge fund and institutional investor holdings data compiled by Insider Monkey, Thomas E. Claugus’s GMT Capital has the number one position in Chemours Co (NYSE:CC), worth close to $44.9 million, amounting to 1.1% of its total 13F portfolio. Coming in second is Trian Partners, with a $31.6 million position; 0.3% of its 13F portfolio is allocated to the stock. Other professional money managers that hold long positions consist of John Petry’s Sessa Capital, David Stemerman’s Conatus Capital Management and D E Shaw.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.